Skip to content
Screener

Capricor Therapeutics CAPR Total Current Assets

Total Current Assets at other companies

Pfizer logo
PfizerPFE
$42.82B-6.6%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$2.22B-16.3%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$2.25B-2.7%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$724.93M+11.8%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$1.02B+48.1%
Cytokinetics logo
CytokineticsCYTK
$1.21B+36.3%

Other financials

Income statement

See full
Revenue--100%
Operating income-$36.8M-47.2%
Net income-$33.9M-39.2%
EPS (diluted)-$0.59-11.3%

Balance sheet

See full
Cash & equivalents$105.4M+266%
Total debt$14.8M+1,083%
Total equity$278.7M+118%
Total assets$326.3M+112%

Cash flow

See full
Operating cash flow-$29.3M-355%
CapEx$5.1M+472%
Free cash flow-$34.4M-369%

Valuation

See full
Market cap$236.86M-42.9%
Enterprise value$146.22M-62.7%

Profitability

See full
Operating margin-778.8%-1,038pp
Net margin-736.6%-981pp
FCF margin-563.9%-954pp

Returns & leverage

See full
Return on equity-56.4%-11.3pp
Debt / equity0.1×0.0×
Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 5:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-060382
Line itemMarch 31, 2026 / (unaudited)December 31, 2025December 31, 2025
Marketable securities173,188,43030,281,603
Receivables59,167
Prepaid expenses and other current assets4,478,8954,751,674
TOTAL CURRENT ASSETS283,088,809322,939,756
PROPERTY AND EQUIPMENT, net28,502,61718,312,238
OTHER ASSETS
Lease right-of-use assets, net13,158,50013,537,820
Other assets1,533,5911,159,480

Item 1. Financial Statements.

FAQ

What is Capricor Therapeutics's total current assets?
Capricor Therapeutics (CAPR) reported total current assets of $283.09M in Q1 2026.
How has Capricor Therapeutics's total current assets changed year-over-year?
Capricor Therapeutics's total current assets increased by 93.6% year-over-year, from $146.25M to $283.09M.
What is the long-term trend for Capricor Therapeutics's total current assets?
Over 5 years (2020 to 2025), Capricor Therapeutics's total current assets has grown at a 57.2% compound annual growth rate (CAGR), from $33.68M to $322.94M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Capricor Therapeutics's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude